Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 15;13:5699–5709. doi: 10.2147/CMAR.S286917

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Kleemann et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Treatment evaluation. (A) Response to T-VEC therapy. Complete responses were observed in three of twelve patients, partial responses in four of twelve patients and stable disease was seen in two patients. Overall response rate was 58.3% (7/12 patients), and disease control rate was 75.0% (9/12 patients). (B) Individual therapy courses. Each lane of the swimmer plot represents the therapy course of one individual in this study over time. The red bars show the time on treatment; black bars represent the follow-up time. Events of response [complete response (CR): green box, partial response (PR): yellow box, stable disease (SD): grey box; progressive disease (PD): black cross], relapse (red triangle) and death (asterisk) are marked.